These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 14576473)

  • 41. Comparison of Alu-PCR, microsatelite instability, and immunohistochemical analyses in finding features characteristic for hereditary nonpolyposis colorectal cancer.
    Debniak T; Gorski B; Cybulski C; Jakubowska A; Kurzawski G; Kladny J; Lubinski J
    J Cancer Res Clin Oncol; 2001 Sep; 127(9):565-9. PubMed ID: 11570578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation.
    Plaschke J; Krüger S; Pistorius S; Theissig F; Saeger HD; Schackert HK
    Int J Cancer; 2002 Feb; 97(5):643-8. PubMed ID: 11807791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical analysis and molecular genetic study of hereditary nonpolyposis colorectal cancer kindreds].
    Luo DC; Cai Q; Sun MH; Ni YZ; Tao CW; Chen ZJ; Shi DR
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):158-62. PubMed ID: 15062061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and biologic heterogeneity of hereditary nonpolyposis colorectal cancer.
    Benatti P; Roncucci L; Ganazzi D; Percesepe A; Di Gregorio C; Pedroni M; Borghi F; Sala E; Scarselli A; Menigatti M; Rossi G; Genuardi M; Viel A; Ponz De Leon M
    Int J Cancer; 2001 Sep; 95(5):323-8. PubMed ID: 11494233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
    Umar A; Boland CR; Terdiman JP; Syngal S; de la Chapelle A; Rüschoff J; Fishel R; Lindor NM; Burgart LJ; Hamelin R; Hamilton SR; Hiatt RA; Jass J; Lindblom A; Lynch HT; Peltomaki P; Ramsey SD; Rodriguez-Bigas MA; Vasen HF; Hawk ET; Barrett JC; Freedman AN; Srivastava S
    J Natl Cancer Inst; 2004 Feb; 96(4):261-8. PubMed ID: 14970275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.
    Schiemann U; Müller-Koch Y; Gross M; Glas J; Baretton G; Muders M; Mussack T; Holinski-Feder E
    Eur J Med Res; 2005 Jan; 10(1):23-8. PubMed ID: 15737950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
    Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
    J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway.
    Llor X; Pons E; Xicola RM; Castells A; Alenda C; Piñol V; Andreu M; Castellví-Bel S; Payá A; Jover R; Bessa X; Girós A; Roca A; Gassull MA;
    Clin Cancer Res; 2005 Oct; 11(20):7304-10. PubMed ID: 16243801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1.
    Thibodeau SN; French AJ; Cunningham JM; Tester D; Burgart LJ; Roche PC; McDonnell SK; Schaid DJ; Vockley CW; Michels VV; Farr GH; O'Connell MJ
    Cancer Res; 1998 Apr; 58(8):1713-8. PubMed ID: 9563488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Expression of cyclooxygenase-2 and relationship with mismatch repair gene and microsatellite instability in hereditary non-polyposis colorectal cancer].
    Zhang YH; Sheng JQ; Geng HG; Han M; Huang JS; Mu H; Han WL; Chen JG; Niu HL; Li AQ; Wu ZT; Li SR
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1377-81. PubMed ID: 19671325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration.
    Takemoto N; Konishi F; Yamashita K; Kojima M; Furukawa T; Miyakura Y; Shitoh K; Nagai H
    Jpn J Clin Oncol; 2004 Feb; 34(2):90-8. PubMed ID: 15067103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancer.
    Frazier ML; Sinicrope FA; Amos CI; Cleary KR; Lynch PM; Levin B; Luthra R
    Oncol Rep; 1999; 6(3):497-505. PubMed ID: 10203581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microsatellite Instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer.
    Salahshor S; Koelble K; Rubio C; Lindblom A
    Lab Invest; 2001 Apr; 81(4):535-41. PubMed ID: 11304573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of microsatellite testing and mismatch repair protein expression on the clinical interpretation of genetic testing in hereditary non-polyposis colorectal cancer.
    Ward R; Meldrum C; Williams R; Mokany E; Scott R; Turner J; Hawkins N; Burgess B; Groombridge C; Spigelman A
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):403-11. PubMed ID: 12200596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds.
    Nakahara M; Yokozaki H; Yasui W; Dohi K; Tahara E
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1057-64. PubMed ID: 9419403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular testing for microsatellite instability and DNA mismatch repair defects in hereditary and sporadic colorectal cancers--ready for prime time?
    Søreide K
    Tumour Biol; 2007; 28(5):290-300. PubMed ID: 17962726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinicopathological and molecular genetic analysis of HNPCC in China.
    Luo DC; Cai Q; Sun MH; Ni YZ; Ni SC; Chen ZJ; Li XY; Tao CW; Zhang XM; Shi DR
    World J Gastroenterol; 2005 Mar; 11(11):1673-9. PubMed ID: 15786548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fhit protein expression in hereditary and sporadic colorectal cancers.
    Hadaczek P; Debniak T; Kurzawski G; Jakubowska A; Huzarski T; Huebner K; Lubiński J
    Pol J Pathol; 2001; 52(3):125-32. PubMed ID: 11769399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.